A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children
Proton pump inhibitors (PPIs) are among the most prescribed drugs worldwide and include omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole. Their use in pediatrics is approved for children older than 1 year, for the short-term treatment of symptomatic gastroesophageal reflux disea...
Saved in:
Main Authors: | Valeria Dipasquale (Author), Giuseppe Cicala (Author), Edoardo Spina (Author), Claudio Romano (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence
by: Valeria Dipasquale, et al.
Published: (2022) -
RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017) -
Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
by: Kenji Ikemura, et al.
Published: (2017) -
Safety of Proton Pump Inhibitors in Pediatric Population: A Systematic Review
by: Deekshitha Alla, et al.
Published: (2024) -
Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023)